Case File
efta-02092119DOJ Data Set 10OtherEFTA02092119
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-02092119
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
ran:
Lesley Grort
Sent
Fri 10/24/2014 11:54:43 AM
Subject: Re: Egenesis & Georgarage LLC
Below is Jeffrey's reply:
please send me the biz plan as outlined on the phone. use of funds for 2 ,5 years. ? I will then
send a structure that i believe works
Sent from my iPhone
On Oct 23, 2014, at 9:43 PM,
Dear Jeffery,
It was nice talking with you on the phone yesterday. I look forward to discussing with you
about the business at eGenesis, in which we deliver human transplantable organ by
engineering animals.
To follow up our last proposal of convertible note, I attached our proposed term sheet in
which we offer 15% discount rate and 8% interest rate for $1.5 million investment
as convertible note.
Alternatively, if you wish, we propose the company pre-money evaluation of $15 million
and offer you 9.09% eGenesis preferred share with your $1.5 million investment.
I look forward to your feedback and I am happy to discuss with you in person.
Best
RRRRRRR*******R*****R13 RR**R*R RR 13 Et
From: Lesley Groff u ect: Conf. Call NOW or in 2 hours
Jeffrey is asking if it would be possible to have the conference call either NOW or in two hours (at
3:45)
Please let me know! (so sorry, but Jeffrey has a meeting he must now attend at 2pm)
Thanks, Lesley
EFTA_R1_00891218
EFTA02092119
032959838v2_Active_ - eGenesis Convertible Bridge Notes_2014109l
(1).docx>
EFTA_R1_00691219
EFTA02092120
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.